Show simple item record

Pharmacoepidemiology of antidiabetic drugs and patients' relation towards drugs and treatment of type 2 diabetes mellitus in the Republic of Srpska

dc.contributor.advisorTomić-Naglić, Dragana
dc.contributor.advisorHorvat, Olga
dc.contributor.otherStokić, Edita
dc.contributor.otherMitrović, Milena
dc.contributor.otherTomić-Naglić, Dragana
dc.contributor.otherHorvat, Olga
dc.contributor.otherMilovanović, Dragan
dc.creatorPopržen, Jelena
dc.date.accessioned2018-10-01T16:36:01Z
dc.date.available2018-10-01T16:36:01Z
dc.date.available2020-07-03T13:24:18Z
dc.date.issued2018-09-20
dc.identifier.urihttps://www.cris.uns.ac.rs/DownloadFileServlet/Disertacija152707315950058.pdf?controlNumber=(BISIS)107390&fileName=152707315950058.pdf&id=11408&source=NaRDuS&language=srsr
dc.identifier.urihttp://nardus.mpn.gov.rs/handle/123456789/9931
dc.identifier.urihttps://www.cris.uns.ac.rs/record.jsf?recordId=107390&source=NaRDuS&language=srsr
dc.identifier.urihttps://www.cris.uns.ac.rs/DownloadFileServlet/IzvestajKomisije152707317382674.pdf?controlNumber=(BISIS)107390&fileName=152707317382674.pdf&id=11409&source=NaRDuS&language=srsr
dc.description.abstractIako je dijabetes melitus (DM) tip 2 je hronično oboljenje čija se stopa značajno povećala poslednjih decenija, podaci o odnosu pacijenta prema leku i lečenju dijabetes melitusa su retki i odnose se na pojedine aspekte terapije. Glavni kamen spoticanja u lečenju dijabetesa jeste nepridržavanje pacijenata propisanim lekovima, što otežava održavanje normalne glikoregulacije i doprinosi razvoju teških komplikacija koje značajno utiču na kvalitet života pacijenata sa DM. Raspolaganje tačnim podacima o upotrebi antidijabetičnim lekova, kao i uvidom u realno stanje o odnosu pacijenata prema leku u lečenju DM tipa 2, omogućava poboljšanje farmakoterapijske prakse i kreiranje intervencije za poboljšanje adherencije pacijenata Ciljevi ovog istraživanja bili su: 1) analiza obima potrošnje i strukture antidijabetičnih lekova na teritoriji Republike Srpske i njihovo poređenje sa upotrebom i strukturom propisivanja u okolnim zemljama kao i državama sa razvijenom farmakoterapijskom praksom; 2) analiza obima potrošnje i strukture antidijabetičnih lekova u opštini Foča i poređenje sa savremenim farmakoterapijskim smernicama; 3) određivanje procenta pokrivenosti antidijabetičnom terapijom pacijenata sa DM tip 2 tokom jedne godine u opštini Foča; 4) određivanje adherencije pacijenata sa DM tipa 2 prema antidijabetičnoj terapiji metodom brojanja tableta/doza insulina i putem validiranog upitnika; 5) određivanje kvaliteta života povezanog sa zdravljem pacijenata sa DM tipa 2 u opštini Foča primenom validiranog upitnika SF-36v2; 6) određivanje prediktora neadherenije kod primene obe metode merenja adherencije u odnosu na karakteristike i kvalitet života pacijenata sa DM tip 2 u opštini Foča. Ispitivanje se sastojalo iz dva dela. U prvom delu sprovedeno je retrospektivno farmakoepidemiološko praćenje upotrebe antidijabetičnih lekova kao i određivanje strukture ovih lekova na teritoriji Republike Srpske u periodu od 01.01.2013. do 31.12.2013.godine i izvršeno je poređenje sa upotrebom i strukturom propisivanja u okolnim zemljama kao i državama sa razvijenom farmakoterapijskom praksom. U drugom delu ispitivanja sprovedeno je farmakoepidemiološko ispitivanje primene antidijabetičnih lekova na nivou same opštine Foča u okviru koje je pored analize obima potrošnje i strukture antidijabetičnih lekova u istom periodu kao i na teritoriji Republike Srpske i poređenja sa savremenim farmakoterapijskim smernicama, određivan i procenta pokrivenosti antidijabetičnom terapijom mereno redovnošću ponovnih popunjavanja recepata od strane lekara opšte prakse tokom jednogodišnjeg perioda. Takođe je sprovedeno i ispitivanje adherencije prema antidijabetičnim lekovima primenom dve različite metode merenja kao i kvalitet života pacijenata sa DM tip 2 između 01.01.2015. i 31.12.2015.godine. Ukupna upotreba antidijabetika za lečenje dijabetesa tip 1 i tip 2 na teritoriji Republike Srpske iznosila je 38,29 DDD/1000st/dan. Upotreba insulina i analoga iznosila je 11,28 DDD/1000st/dan. Ukupna upotreba oralnih lekova koji snižavaju glukozu i krvi, isključujući insuline iznosila je 27,01 DDD/1000st/dan, a metformin je najčešće korišćeni predstavnik. Sličan obim i struktura upotrebe antidijabetičnih lekova utvrđena je i u opštini Foča. Procenat pokrivenosti antidijabetičnom terapijom pacijenata sa DM tip 2 tokom jedne godine u opštini Foča iznosio je više od 94,91%. Adherencija određivana metodom brojanja tableta/doza insulina iznosila je 52,3%, a merena primenom validiranog upitnikom iznosila je svega 44,9%. Statistički značajni prediktori neadherencije određivane primenom metode brojanja tableta/doza insulina su doplata cena leka kao i niži skor dimenzije mentalnog zdravlja kada je u pitanju kvalitet života. Prediktori neadherencije merene primenom validiranog upitnikom bili su muški pol, kao i niži skor dimenzije mentalnog kao i fizičkog zdravlja kada je u pitanju kvalitet života. Na osnovu ovih saznanja, intervencije za poboljšanje adherencije pacijenata bi bile usmerene na edukaciju pacijenata muškog pola, zatim na smanjivanje izdataka pacijenata za lekove, što će doprineti i boljem kvalitetu života ovih pacijenata.sr
dc.description.abstractAlthough diabetes mellitus (DM) type 2 is a chronic disease whose rate has increased significantly in recent decades, data on the patient's attitudes towards the medicine and the treatment of diabetes mellitus are rare and relate to individual aspects of the therapy. The main stumbling block in the treatment of diabetes is not taking prescribed drugs regularly, which makes it difficult to maintain normal glycoregulation and contribute to the development of severe complications that significantly affect the quality of life of patients with DM. The disposition of accurate data on the use of antidiabeticdrugs, as well as the insight into the real state of the patient's relationship with the medication in the treatment of DM type 2, enables the improvement of pharmacotherapeutic practice and the creation of an intervention to improve patient adherence. The objectives of this research were: 1) analysis of the volume of consumption and structure of anti-diabetic medicines on the territory of the Republic of Srpska and their comparison with the use and structure of prescribing in the surrounding countries as well as countries with developed pharmacotherapeutic practice; 2) analysis of the volume of consumption and structure of antidiabetic drugs in the municipality of Foča and comparison with modern pharmacotherapeutic guidelines; 3) determining the percentage of coverage with antidiabetic therapy of patients with DM type 2 during one year in the municipality of Foča; 4) determining the adherence of patients with DM type 2 in antidiabetic therapy by the method of pill counts /volume of insulin and by validated questionnaire; 5) determining the quality of life associated with the health of patients with DM type 2 in the municipality of Foča using the validated questionnaire SF-36v2; 6) determination of the predictor of nonadherence in the application of both methods of adherence measurement in relation to the characteristics and quality of life of patients with DM type 2 in the municipality of Foča. The investigation consisted of two parts. In the first part, a retrospective pharmacoepidemiological monitoring of the use of antidiabetic drugs was carried out, as well as determining the structure of these drugs in the territory of the Republic of Srpska in the period from January, 1st 2013 until December, 31st 2013, and a comparison was made with the use and prescription structure in neighboring countries as well as countries with developed pharmacotherapeutic practices. In the second part of the study, a pharmacoepidemiological study was carried out on the use of antidiabetic drugs at the level of the municipality of Foča itself, in which, besides analyzing the volume of consumption and structure of anti-diabetic drugs in the same period as in the territory of the Republic of Srpska and comparison with modern pharmacotherapeutic guidelines, the percentage of coverage by antidiabetic therapy was measured by the regularity of the prescription prescribed by the general practitioner over a one-year period. Medication adherence to antidiabetic drugs was also carried out using two different methods of measurement as well as the quality of life of patients with DM type 2 between January, 1st 2015 and December, 31st 2015. The total use of antidiabetic for the treatment of type 1 diabetes and type 2 in the territory of the Republic of Srpska was 38.29 DDD / 1000st / day. The use of insulin and analogs was 11.28 DDD / 1000st / day. The total use of blood glucose lowering drugs , excluding insulins, was 27.01 DDD / 1000st / day, and metformin is the most commonly used representative. A similar volume and structure of the use of anti-diabetic drugs was also determined in the municipality of Foča. The percentage of coverage of antidiabetic therapy of patients with DM type 2 during one year in the municipality of Foca amounted to more than 94.91%. Adherence determined by the pill counts and the volume of insulin method was 52.3%, and measured by applying the validated questionnaire was only 44.9%. Statistically significant predictors of nonadherence determined by the method of pill counts/volume of insulin are copayment, a fix fee for prescription made by patients as well as the lower score of the mental health dimension when it comes to quality of life. The non-adherence predictors measured using the validated questionnaire were the male sex, as well as a lower score of the mental dimension as well as physical health when it comes to quality of life. Based on these findings, interventions to improve patient adherence would focus on health education of male patients, and policy changes regarding availability of antidiabetic medication through copayment reductions , which will contribute to a better quality of life for these patients.en
dc.languagesr (latin script)
dc.publisherУниверзитет у Новом Саду, Медицински факултетsr
dc.rightsopenAccessen
dc.sourceУниверзитет у Новом Садуsr
dc.subjectdijabetes melitus tip 2sr
dc.subjectDiabetes Mellitusen
dc.subjectType 2en
dc.subjectfarmakoepidemiologijasr
dc.subjecthipoglikemijski lekovisr
dc.subjectpacijentisr
dc.subjectadherencija prema lekovimasr
dc.subjectkvalitet životasr
dc.subjectBosna i Hercegovinasr
dc.subjectPharmacoepidemiologyen
dc.subjectHypoglycemic Agentsen
dc.subjectPatientsen
dc.subjectMedication Adherenceen
dc.subjectQuality of Lifeen
dc.subjectBosnia and Herzegovinaen
dc.titleFarmakoepidemiologija antidijabetičnih lekova i odnos pacijenata prema leku i lečenju dijabetes melitusa tipa 2 u Republici Srpskojsr
dc.title.alternativePharmacoepidemiology of antidiabetic drugs and patients' relation towards drugs and treatment of type 2 diabetes mellitus in the Republic of Srpskaen
dc.typedoctoralThesissr
dc.rights.licenseBY-NC-ND
dcterms.abstractТомић-Наглић, Драгана; Хорват, Олга; Стокић, Едита; Митровић, Милена; Томић-Наглић, Драгана; Хорват, Олга; Миловановић, Драган; Попржен Јелена; Фармакоепидемиологија антидијабетичних лекова и однос пацијената према леку и лечењу дијабетес мелитуса типа 2 у Републици Српској; Фармакоепидемиологија антидијабетичних лекова и однос пацијената према леку и лечењу дијабетес мелитуса типа 2 у Републици Српској;
dc.identifier.fulltexthttp://nardus.mpn.gov.rs/bitstream/id/33991/Disertacija17618.pdf
dc.identifier.fulltexthttp://nardus.mpn.gov.rs/bitstream/id/33992/IzvestajKomisije17618.pdf


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record